The REACH Annex XVII CMR substances update 2026 establishes new restrictions which directly affect companies that produce goods for sale in the European Union market. The introduction of 22 new carcinogenic and mutagenic and reprotoxic substances through changing CLP regulations forces organizations to evaluate their product formulas and supplier records and market entry plans. CEOs and CFOs and compliance leaders view this regulatory update as a threat to their business operations. Non-compliance results in product recalls which limit market access and create supply chain problems and damage to company image. Suppose distribution controls and labeling regulations require businesses to monitor their supply chains through multiple levels of operation then this requirement creates additional difficulties for them. Organizations can no longer use traditional compliance methods which include spreadsheets and manual audits and reactive monitoring. The AI-driven compliance platforms provid
